Can Lion's Mane Support Daily Focus? Understanding NGF and Focus

Research on Lion's Mane and Daily Function: An Emerging Area of Investigation

Key Takeaways

• Lion's Mane mushroom (Hericium erinaceus) occupies an unusual position in the supplement world. It has deep roots in tra
• What makes Lion's Mane different from many other botanical ingredients is the specificity of the proposed mechanism. Rat
• This article examines the key studies that have shaped the scientific conversation around Lion's Mane. It is important t

By the Lumnira Research Desk

Introduction: A Fungus Under the Microscope

Lion's Mane mushroom (Hericium erinaceus) occupies an unusual position in the supplement world. It has deep roots in traditional East Asian food and wellness practices, where it has been consumed for centuries. Yet it has also become the subject of a growing number of modern scientific investigations, with researchers in Japan, Europe, and Australia examining whether compounds isolated from Lion's Mane might influence daily function in measurable ways. The research is still in its early stages compared to well-established dietary compounds like creatine or omega-3 fatty acids, and many of the existing studies are small in scale. But the findings have been consistent enough to warrant attention.

What makes Lion's Mane different from many other botanical ingredients is the specificity of the proposed mechanism. Rather than operating as a general tonic, researchers have focused on a particular class of compounds found in the mushroom, including erinacines and hericenones, and their potential to influence nerve growth factor (NGF) synthesis. NGF is a protein that plays a role in the maintenance and survival of certain types of neurons, and the hypothesis that dietary compounds might influence NGF levels has driven a distinct line of investigation over the past two decades.

This article examines the key studies that have shaped the scientific conversation around Lion's Mane. It is important to note that this area of research is exploratory. Most studies have been conducted in relatively small groups of participants, over relatively short periods, and the findings, while encouraging, are preliminary. Researchers in the field consistently call for larger, longer-term trials before firm conclusions can be drawn. The information presented here reflects the published evidence as of mid-2026.

What Is Lion's Mane and Why Has It Attracted Research Interest?

Lion's Mane (Hericium erinaceus) is a white, shaggy mushroom native to North America, Europe, and Asia. It grows on hardwood trees, particularly oak and beech, and has been used in traditional East Asian cooking and wellness practices for centuries. The mushroom's common name comes from its appearance: a cascading mass of white spines that resembles a lion's mane.

From a research perspective, interest in Lion's Mane centers on two groups of bioactive compounds: hericenones, which are found primarily in the fruiting body of the mushroom, and erinacines, which are found primarily in the mycelium. Both groups of compounds belong to a chemical class called cyathane diterpenoids, and both have been investigated in laboratory settings for their potential to cross the natural barrier and influence the production of nerve growth factor (NGF) [1].

NGF is a neurotrophin, a type of protein that supports the survival, maintenance, and function of neurons. It is particularly important for cholinergic neurons in the basal forebrain, which are involved in attention, learning, and memory. The hypothesis that dietary compounds might influence NGF levels has driven a line of research stretching back to the early 2000s, when Japanese researchers led by Hirokazu Kawagishi first isolated hericenones and erinacines from Hericium erinaceus and reported that they stimulated NGF synthesis in cultured cells [1].

It is important to understand what this laboratory finding does and does not mean. Cell culture experiments can identify compounds with interesting biological activity, but they do not demonstrate that the same activity occurs in humans after oral consumption. The compound must survive digestion, be absorbed into the bloodstream, cross the natural barrier, and reach target tissues at sufficient concentrations. Each of these steps represents a hurdle that must be cleared before a laboratory finding can translate into a physiological effect. The human studies reviewed below represent attempts to determine whether the effects observed in the laboratory translate to measurable outcomes in living people.

Saitsu 2019: Cognitive Scores in Adults Over 50

One of the more widely cited human studies on Lion's Mane was conducted by Yuusuke Saitsu and colleagues at the University of Tokyo and published in 2019 in the journal Biomedical Research. The study used a double-blind, placebo-controlled design with 31 participants aged 50 and older who reported subjective cognitive concerns but did not have a diagnosed cognitive condition. Participants were randomly assigned to receive either 3.2 grams of Lion's Mane fruiting body powder per day or a placebo for 12 weeks [2].

Cognitive function was assessed using the Mini-Mental State Examination (MMSE), a widely used clinical screening tool that evaluates orientation, attention, memory, language, and visuospatial ability. The MMSE is scored on a 30-point scale, with higher scores indicating better daily function. Participants were assessed at baseline, at 4 weeks, 8 weeks, and 12 weeks [2].

The results showed that participants in the Lion's Mane group experienced an increase in MMSE scores over the course of the 12-week study. The increase, while modest in absolute terms, was statistically significant compared to the placebo group. At the 12-week mark, the mean MMSE score in the Lion's Mane group had risen from approximately 25.0 at baseline to approximately 26.1, while the placebo group remained relatively stable. The between-group difference reached statistical significance at weeks 8, 12, and 16 (the follow-up assessment four weeks after supplementation ended) [2].

Several aspects of this study are worth noting. First, the participant group was relatively small at 31 individuals, which is common in early-stage human research but limits the generalizability of the findings. Second, the MMSE, while well-validated, is a screening tool rather than a comprehensive cognitive assessment, and it may not be sensitive to subtle changes in specific cognitive domains. Third, the Lion's Mane preparation used was 3.2 grams of dried fruiting body powder, which is a relatively high dose and would contain a different profile of compounds, predominantly hericenones rather than erinacines, compared to mycelium-based preparations [2].

Despite these limitations, the Saitsu study was important because it represented one of the first double-blind, placebo-controlled trials to report measurable changes associated with Lion's Mane supplementation in active adults. It provided a proof-of-concept that warranted follow-up investigation with larger samples and more comprehensive cognitive assessments.

Docherty 2024: Acute Effects on Processing Speed

While the Saitsu study examined long-term supplementation over 12 weeks, a different research group led by Sarah Docherty at Northumbria University in the United Kingdom took a different approach. Their 2024 study, published in Nutrients, investigated whether a single dose of Lion's Mane could produce acute, measurable effects on cognitive performance within hours of consumption [3].

The study recruited 41 healthy young adults and used a randomized, double-blind, placebo-controlled, crossover design. Participants received a single dose of 1.8 grams of Lion's Mane extract or a placebo, with at least one week between conditions. Cognitive testing was conducted 60 minutes after consumption, a time window chosen based on pharmacokinetic data suggesting that bioactive compounds from Lion's Mane reach peak plasma concentrations within 60 to 120 minutes of oral intake [3].

The primary outcome was performance on the Stroop task, a classic measure of cognitive processing speed and attentional control. In the Stroop task, participants are shown color words printed in either matching or mismatching ink colors and must name the ink color while ignoring the word meaning. The task measures the speed at which the brain can resolve conflicting information, a process that engages prefrontal attentional networks [3].

The researchers found that participants who received Lion's Mane showed significantly faster performance on the Stroop task at the 60-minute mark compared to those who received placebo. The effect was specific to the condition in which the word and color conflicted, which is the most cognitively demanding version of the task. This pattern is consistent with the idea that Lion's Mane compounds may influence attentional processing speed, particularly under conditions of cognitive load [3].

The Docherty study is notable for several reasons. It demonstrated that effects could be observed acutely, within a single testing session, which is a different temporal pattern than the gradual improvement observed in longer-term studies like Saitsu 2019. It also used a well-characterized cognitive task with established mental correlates, making it possible to hypothesize about the brain networks involved. The sample size of 41, while still modest, was larger than many earlier Lion's Mane studies. And the crossover design, in which each participant served as their own control, helped reduce the influence of individual differences on the results [3].

However, the study also had limitations. The acute effects demonstrated at 60 minutes do not tell us whether repeated daily supplementation over weeks or months would produce cumulative or sustained benefits. The study population was young and healthy, meaning the results may not generalize to active adults or to individuals with specific cognitive concerns. And as with all single-dose studies, the findings need to be replicated by independent laboratories before they can be considered established.

îerneliì Bizjak 2024: Erinacine A, BDNF, and Cognitive Assessment

One of the more mechanistically detailed recent studies was conducted by Katja îerneliì Bizjak and colleagues and published in 2024. This study examined a Lion's Mane preparation enriched with erinacine A, a specific cyathane diterpenoid that has shown particularly potent NGF-stimulating activity in laboratory studies. The researchers enrolled 33 participants and assessed daily function using a battery of standardized neuropsychological tests [4].

What set this study apart was its inclusion of a biological marker: brain-derived neurotrophic factor (BDNF). BDNF is a protein that, like NGF, belongs to the neurotrophin family and is involved in cellular survival, synaptic plasticity, and daily function. BDNF levels can be measured in blood samples and have been studied as a marker of adaptability. The researchers hypothesized that erinacine A-enriched Lion's Mane might influence BDNF levels, providing a measurable biological correlate to any changes observed [4].

The study found that participants who received the erinacine A-enriched Lion's Mane showed improvements on several cognitive measures. Performance on tests of verbal learning and memory showed the most consistent changes. The researchers also reported that BDNF levels increased in the Lion's Mane group compared to baseline, though the magnitude of this increase was moderate and showed variability between participants [4].

The BDNF finding is noteworthy because it provides one of the first pieces of human evidence linking Lion's Mane consumption to a measurable change in a neurobiological marker. Previous studies had relied entirely on cognitive tests, which, while ecologically valid, do not reveal anything about the underlying biology. If the BDNF finding can be replicated in larger studies, it would strengthen the case that Lion's Mane compounds are exerting effects through the proposed neurotrophic mechanism rather than through some other, unidentified pathway [4].

However, the study also had significant limitations that the authors acknowledged. The sample size of 33 participants is small by the standards of human clinical research, and the absence of a placebo control group makes it difficult to rule out expectancy effects or natural fluctuations in cognitive performance over time. The BDNF measurement, while promising, is a peripheral blood measure and does not provide direct information about BDNF levels in the brain. These caveats mean that the îerneliì Bizjak study should be viewed as hypothesis-generating rather than conclusive [4].

Daoust 2026: Visual Attention, Working Memory, and Sleep Quality

The most recently published and largest human study to date was conducted by Daoust and colleagues and appeared in 2026. This study enrolled 109 participants between the ages of 40 and 75, making it roughly three times larger than the Saitsu 2019 study and substantially larger than any previous Lion's Mane trial. Participants received 2 grams of Lion's Mane per day for 8 weeks in a randomized, double-blind, placebo-controlled design [5].

The cognitive assessment battery was more comprehensive than in earlier studies. The researchers measured visual attention using a sustained attention to response task (SART), which requires participants to respond rapidly to frequent targets while withholding responses to rare non-targets. Working memory was assessed using a spatial working memory task that measures the ability to hold and manipulate spatial information over short intervals. The researchers also assessed subjective sleep quality using a validated questionnaire, a novel addition given that earlier Lion's Mane studies had focused exclusively on cognitive measures [5].

The results showed that Lion's Mane supplementation was associated with improvements in visual attention and working memory compared to placebo. The effect on visual attention was particularly notable, with participants in the Lion's Mane group showing fewer lapses in sustained attention during the SART, a measure that has been linked to prefrontal cortex function. Working memory performance also improved, though the effect size was slightly smaller than for attention. Sleep quality scores improved in the Lion's Mane group as well, suggesting that the effects of supplementation may extend beyond cognition to include aspects of daily functioning that support daily performance [5].

The Daoust study represents the most robust evidence to date for Lion's Mane's effects on daily function in everyday and active adults. The larger sample size, the inclusion of both objective cognitive measures and subjective sleep quality assessments, and the use of a well-characterized, standardized Lion's Mane preparation all contribute to the strength of the findings. The age range of 40 to 75 is particularly relevant because it targets the demographic window in which many people begin to notice changes in cognitive stamina and attention, and for whom dietary strategies to support daily focus are most commonly sought [5].

Even with these strengths, the Daoust study does not close the book on Lion's Mane research. The 8-week supplementation period, while longer than the acute studies, is still relatively short. Whether the cognitive benefits observed at 8 weeks are maintained, grow, or plateau over longer periods is unknown. The study also did not include brain imaging or biomarker measures, which means the mental mechanisms underlying the observed changes remain speculative. And as with any single study, replication by independent research groups will be essential before the findings can be considered established.

Several earlier studies also contribute to the broader evidence base. Mori and colleagues published a study in 2009 in Phytotherapy Research that examined Lion's Mane in 30 active adults with mild cognitive concerns. Participants received 3 grams of Lion's Mane per day for 16 weeks. The study reported improvements in a daily function scale compared to placebo, though the small sample size and the use of a non-standard assessment tool limit the interpretability of the findings [6].

Looking across the available evidence, a consistent pattern emerges: multiple independent research groups, working with different populations, different Lion's Mane preparations, and different cognitive measures, have reported that supplementation is associated with measurable improvements in daily function. The effects are most consistent in domains related to attention, processing speed, and working memory, and appear to be present both acutely after a single dose and cumulatively over weeks of supplementation. However, the studies remain small to moderate in size, relatively short in duration, and in need of replication in larger, longer-term trials with more comprehensive biological measures.

For individuals interested in Lion's Mane, the research suggests that this is an area of active scientific investigation with preliminary evidence that warrants continued study. The mushroom has a long history of culinary use and is generally well-tolerated, which makes it a relatively low-risk candidate for further research. The key unknowns, including optimal dosing, the comparative effects of fruiting body versus mycelium preparations, and the long-term sustainability of any cognitive benefits, will need to be addressed by future research before more definitive guidance can be offered.

Frequently Asked Questions

What is this article about?

Lion's Mane mushroom (Hericium erinaceus) occupies an unusual position in the supplement world. It has deep roots in traditional East Asian food and wellness practices, where it has been consumed for centuries. Yet it has also become the subject of a growing number of modern scientific investigations, with researchers in Japan, Europe, and Australia examining whether compounds isolated from Lion's

What Is Lion's Mane and Why Has It Attracted Research Interest?

Lion's Mane (Hericium erinaceus) is a white, shaggy mushroom native to North America, Europe, and Asia. It grows on hardwood trees, particularly oak and beech, and has been used in traditional East Asian cooking and wellness practices for centuries. The mushroom's common name comes from its appearance: a cascading mass of white spines that resembles a lion's mane.

What is saitsu 2019: cognitive scores in adults over 50?

One of the more widely cited human studies on Lion's Mane was conducted by Yuusuke Saitsu and colleagues at the University of Tokyo and published in 2019 in the journal Biomedical Research. The study used a double-blind, placebo-controlled design with 31 participants aged 50 and older who reported subjective cognitive concerns but did not have a diagnosed cognitive condition. Participants were ran

What is docherty 2024: acute effects on processing speed?

While the Saitsu study examined long-term supplementation over 12 weeks, a different research group led by Sarah Docherty at Northumbria University in the United Kingdom took a different approach. Their 2024 study, published in Nutrients, investigated whether a single dose of Lion's Mane could produce acute, measurable effects on cognitive performance within hours of consumption [3].

What is îerneliì bizjak 2024: erinacine a, bdnf, and cognitive assessment?

One of the more mechanistically detailed recent studies was conducted by Katja îerneliì Bizjak and colleagues and published in 2024. This study examined a Lion's Mane preparation enriched with erinacine A, a specific cyathane diterpenoid that has shown particularly potent NGF-stimulating activity in laboratory studies. The researchers enrolled 33 participants and assessed daily function using a ba

What is daoust 2026: visual attention, working memory, and sleep quality?

The most recently published and largest human study to date was conducted by Daoust and colleagues and appeared in 2026. This study enrolled 109 participants between the ages of 40 and 75, making it roughly three times larger than the Saitsu 2019 study and substantially larger than any previous Lion's Mane trial. Participants received 2 grams of Lion's Mane per day for 8 weeks in a randomized, dou

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.